Commentary

You have full text access to this OnlineOpen article

Increased risk of brain metastases in patients with HER-2/neu-positive breast carcinoma

  1. Ramin Altaha M.D.†,*,
  2. Edward Crowell M.D.,
  3. Gerry Hobbs Ph.D.,
  4. Gerry Higa Pharm.D.,
  5. Jame Abraham M.D.

Article first published online: 1 DEC 2004

DOI: 10.1002/cncr.20813

Issue

Cancer

Cancer

Volume 103, Issue 3, pages 442–443, 1 February 2005

Additional Information

How to Cite

Altaha, R., Crowell, E., Hobbs, G., Higa, G. and Abraham, J. (2005), Increased risk of brain metastases in patients with HER-2/neu-positive breast carcinoma. Cancer, 103: 442–443. doi: 10.1002/cncr.20813

Author Information

  1. Section of Hematology/Oncology, Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, West Virginia

  1. †

    Fax: (304) 293-2519

*Section of Hematology/Oncology, Mary Babb Randolph Cancer Center, Robert C. Byrd Health Sciences Center, West Virginia University Hospitals, P.O. Box 9162, Morgantown, WV 26506-9162

Publication History

  1. Issue published online: 20 JAN 2005
  2. Article first published online: 1 DEC 2004
  3. Manuscript Revised: 8 OCT 2004
  4. Manuscript Accepted: 8 OCT 2004
  5. Manuscript Received: 21 JUN 2004

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (40K)

Data from previous studies have indicated that overexpression of HER-2/neu appears to be correlated with more aggressive disease, increased metastatic potential, and poorer prognosis in patients with breast carcinoma.

View Full Article (HTML) Get PDF (40K)